Skip to main content
. 2019 Aug 9;12:75. doi: 10.1186/s13048-019-0550-0

Fig. 2.

Fig. 2

The expression of the CN in ovarian cancer with later-stage or early-stage. The different subtypes of human ovarian cancer, including (a) total type, (b) clear cell carcinoma, (c) serous carcinoma, and (d) papillary serous cystadenocarcinoma, were examined the expression of CN via IHC staining (CN-positive percentage). The results were presented as the percentage-change in CN expression of later-stage tumor tissue (stage III~IV) relative to that in early-stage tumor tissue (stage I~II). The CN expression of serous carcinoma was significantly higher in later-stage tumor tissue than in early-stage tumor tissue (p < 0.05)